Omkar Speciality Chemicals has decided to foray into Contract Research and Manufacturing Services (CRAMS) business in order to move up the value chain in the growing pharma industry with the help of its strong operational efficiencies backed by robust R&D focused initiatives and multiproduct delivery capabilities.
The key growth drivers for company in the CRAMS segment are strong order pipeline which will culminate into high margin commercial manufacturing opportunities, growing client base that will help our company to sustainably build a diversified product portfolio and operational efficiencies driven by strong R&D focused initiatives and multi-product delivery capability.
Omkar Speciality Chemicals is one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: